Close Menu

NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis announced it has received a €2.5 million ($2.7 million) grant from the Flemish Agency for Innovation & Entrepreneurship (IWT) to expand its manufacturing capacity.

The award comes under the agency's Strategic Transformation Support program and will be used to support manufacturing of the firm's PCR-based Idylla diagnostic platform and assays. Funds will also be used to support training and education for workers at its Mechelen, Belgium facility.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.